<DOC>
	<DOCNO>NCT00477139</DOCNO>
	<brief_summary>This pilot study gather preliminary data baseline immunologic status patient HER-2 ( + ) breast cancer establish immune monitor laboratory future clinical trial .</brief_summary>
	<brief_title>A Pilot Study Evaluating Immunologic Status Patients With HER2+ Breast Cancer</brief_title>
	<detailed_description>This pilot study gather preliminary data baseline immunologic status patient HER-2 ( + ) breast cancer establish immune monitor laboratory future clinical trial . We ask 10 patient HER-2 ( + ) breast cancer stable condition reasonable health participate study . The study establish immune monitor correlative study do patient HER-2 ( + ) breast cancer . The immunologic test do ELISpot , lymphocyte proliferation , intracellular cytokine staining , lymphocyte immunophenotyping , ELISA .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age &gt; = 18 year age Histologically document breast cancer ( hormone receptor ( ER/PR ) status may either positive negative ) without metastatic disease . HER2 ( + ) determine one follow measurement . NOTE : HER2 ( + ) assessment may initial diagnosis need repeat metastatic lesion Immunohistochemistry ( IHC ) 3+ , FISH + ( HER2 gene signal centromere 17 signal &gt; 2 ) No transfusion dependent patient transfusion within 30 day leukopheresis Documented lab within 7 day donation consist : WBC &gt; 4.0 K/ul &amp; &lt; 11.0 K/ul platelet count &gt; 150,000/mm3 hemoglobin &gt; 11.0 g/dl . Hematocrit &gt; 33 % Weight &gt; 110 lb No blood donation last 8 week ( blood sample take standard care less 30 cc/week acceptable ) Patients must active unresolved infection . No cold flu sympton time donation No prior myocardial infarction active cardiac disease ( e.g . congestive heart failure , clinically significant cardiac valvular disease arrhythmia require medication , angina pectoris , uncontrolled hypertension , clinically significant pericardial effusion ) All patient must give sign write informed consent . ECOG Performance Score 0 1 . Women childbearing potential must negative serum urine pregnancy test The presence another active malignancy Pregnant , lactating , nursing Patients prior myocardial infarction active cardiac disease ( e.g . congestive heart failure , clinically significant cardiac valvular disease arrhythmia require medication , angina pectoris , uncontrolled hypertension , clinically significant pericardial effusion )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>